Your browser version may not work well with NCBI's Web applications. More information here...
1: Bioorg Med Chem Lett. 1998 Sep 22;8(18):2563-8.Click here to read Links

Benzylamine-based selective and orally bioavailable inhibitors of thrombin.

Biotech Research Institute, LG Chemical Ltd./Research Park, Taejon, Korea.

A series of p-aminomethylphenylalanine derivatives were investigated as novel thrombin inhibitors. This study led to potent inhibitors of thrombin (Ki up to 3.3 nM) that are trypsin-selective, highly orally bioavailable in rats, and highly permeable across Caco-2 cells. The P1 benzylamine binding mode in the thrombin active site was identified by X-ray crystallographic analysis.

PMID: 9873581 [PubMed - indexed for MEDLINE]